In conclusion, although hypothalamic HIF2α/HIFβ is more physiologically relevant to metabolic regulation, both HIF2α and HIF1α hold significant therapeutic potentials and can be targeted, individually or in combination, in order to counteract obesity and related metabolic diseases. Here, HIF1A is linked to metabolic disease.